These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 28245520

  • 1. Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.
    Schaper F, de Leeuw K, Horst G, Maas F, Bootsma H, Heeringa P, Limburg PC, Westra J.
    Clin Exp Immunol; 2017 Jun; 188(3):412-419. PubMed ID: 28245520
    [Abstract] [Full Text] [Related]

  • 2. High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus.
    Abdulahad DA, Westra J, Bijzet J, Limburg PC, Kallenberg CG, Bijl M.
    Arthritis Res Ther; 2011 May 06; 13(3):R71. PubMed ID: 21548924
    [Abstract] [Full Text] [Related]

  • 3. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
    Wirestam L, Schierbeck H, Skogh T, Gunnarsson I, Ottosson L, Erlandsson-Harris H, Wetterö J, Sjöwall C.
    Arthritis Res Ther; 2015 Nov 23; 17():338. PubMed ID: 26596890
    [Abstract] [Full Text] [Related]

  • 4. Association of anti-CLIC2 and anti-HMGB1 autoantibodies with higher disease activity in systemic lupus erythematosus patients.
    Syahidatulamali CS, Wan Syamimee WG, Azwany YN, Wong KK, Che Maraina CH.
    J Postgrad Med; 2017 Nov 23; 63(4):257-261. PubMed ID: 28862243
    [Abstract] [Full Text] [Related]

  • 5. Anti-high mobility group box 1 (anti-HMGB1) antibodies are not related to the occurrence of cutaneous lesions in systemic lupus erythematosus.
    Tan G, Zhu N, Shi Z, Meng Z, Yu M, Li K, Yin J, Wei K, Mi X, Wang L.
    Scand J Rheumatol; 2015 Nov 23; 44(2):150-6. PubMed ID: 25439526
    [Abstract] [Full Text] [Related]

  • 6. Lupus antibodies to the HMGB1 chromosomal protein: epitope mapping and association with disease activity.
    Hayashi A, Nagafuchi H, Ito I, Hirota K, Yoshida M, Ozaki S.
    Mod Rheumatol; 2009 Nov 23; 19(3):283-92. PubMed ID: 19214652
    [Abstract] [Full Text] [Related]

  • 7. B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time.
    Becker-Merok A, Nikolaisen C, Nossent HC.
    Lupus; 2006 Nov 23; 15(9):570-6. PubMed ID: 17080911
    [Abstract] [Full Text] [Related]

  • 8. Elevated Concentrations of Serum Immunoglobulin Free Light Chains in Systemic Lupus Erythematosus Patients in Relation to Disease Activity, Inflammatory Status, B Cell Activity and Epstein-Barr Virus Antibodies.
    Draborg AH, Lydolph MC, Westergaard M, Olesen Larsen S, Nielsen CT, Duus K, Jacobsen S, Houen G.
    PLoS One; 2015 Nov 23; 10(9):e0138753. PubMed ID: 26402865
    [Abstract] [Full Text] [Related]

  • 9. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K.
    Scand J Rheumatol; 2007 Nov 23; 36(4):291-8. PubMed ID: 17763207
    [Abstract] [Full Text] [Related]

  • 10. Anti-CII antibody as a novel indicator to assess disease activity in systemic lupus erythematosus.
    He C, Mao T, Feng Y, Song T, Qin C, Yan R, Feng P.
    Lupus; 2015 Nov 23; 24(13):1370-6. PubMed ID: 26048288
    [Abstract] [Full Text] [Related]

  • 11. Association of Serum Ferritin Levels with Hematological Manifestations in Systemic Lupus Erythematosus Patients from Western India.
    Pradhan V, Pandit P, Rajadhyaksha A, Patwardhan M, Surve P, Kamble P, Lecerf M, Bayry J, Kaveri S, Ghosh K, Nadkar MY.
    J Assoc Physicians India; 2016 May 23; 64(5):14-18. PubMed ID: 27735143
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic value of serum high-mobility group box-1 in pediatric systemic lupus erythematosus.
    Hossny E, El-Ghoneimy D, Soliman DA, Ashour A.
    Int J Rheum Dis; 2019 Aug 23; 22(8):1402-1409. PubMed ID: 30938057
    [Abstract] [Full Text] [Related]

  • 13. Measuring serum levels of high-mobility group box 1 by enzyme-linked immunosorbent assay does not identify bacterial infections in patients with systemic lupus erythematosus.
    Tang KT, Hsieh TY, Chen YM, Hsieh CW, Chen YH, Chen DY.
    Lupus; 2014 Aug 23; 23(9):926-34. PubMed ID: 24704776
    [Abstract] [Full Text] [Related]

  • 14. [The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases].
    Quattrocchi P, Barrile A, Bonanno D, Giannetto L, Patafi M, Tigano V, Ferlazzo B.
    Reumatismo; 2005 Aug 23; 57(2):109-13. PubMed ID: 15983634
    [Abstract] [Full Text] [Related]

  • 15. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
    Tripathy R, Panda AK, Das BK.
    Lupus; 2015 Jan 23; 24(1):82-9. PubMed ID: 25253568
    [Abstract] [Full Text] [Related]

  • 16. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC.
    Arthritis Res Ther; 2006 Jan 23; 8(6):R162. PubMed ID: 17062137
    [Abstract] [Full Text] [Related]

  • 17. Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity.
    Sellam J, Proulle V, Jüngel A, Ittah M, Miceli Richard C, Gottenberg JE, Toti F, Benessiano J, Gay S, Freyssinet JM, Mariette X.
    Arthritis Res Ther; 2009 Jan 23; 11(5):R156. PubMed ID: 19832990
    [Abstract] [Full Text] [Related]

  • 18. Autoantibodies Targeting Ficolin-2 in Systemic Lupus Erythematosus Patients With Active Nephritis.
    Colliard S, Jourde-Chiche N, Clavarino G, Sarrot-Reynauld F, Gout E, Deroux A, Fougere M, Bardin N, Bouillet L, Cesbron JY, Thielens NM, Dumestre-Pérard C.
    Arthritis Care Res (Hoboken); 2018 Aug 23; 70(8):1263-1268. PubMed ID: 29045037
    [Abstract] [Full Text] [Related]

  • 19. Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjögren's syndrome.
    Du Y, Su Y, He J, Yang Y, Shi Y, Cui Y, Luo C, Wu X, Liu X, Hu F, Ma X, Zheng L, Zhang J, Zuo X, Sheng Y, Wu L, Zhang X, Guo J, Li Z.
    Ann Rheum Dis; 2015 Nov 23; 74(11):2070-5. PubMed ID: 24906639
    [Abstract] [Full Text] [Related]

  • 20. [The application of combined detection of autoantibodies in primary Sjögren's syndrome].
    He J, Fang W, Li ZG.
    Zhonghua Nei Ke Za Zhi; 2008 May 23; 47(5):366-8. PubMed ID: 18953942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.